Home About My Work Contact Recognition Blog Connect With Me
Dr. Ratnesh Jain
Ecosystem Builder
Entrepreneur
Innovator
Strategist
DR. RATNESH JAIN

Founder & Director, Mumbai Biocluster.

Innovating Biopharmaceutical Solutions | Empowering the Next Generation

Advising biopharma, investors and innovators on how to design, de-risk and scale biologics, vaccines and advanced therapies from India to the world.

Explore My Work
Innovating Biopharmaceutical Solutions

Pioneering the Future of Biopharma Ecosystems

Dr. Ratnesh Jain is dedicated to empowering the next generation of scientists and entrepreneurs. By bridging the gap between disruptive academic research and commercial industrial excellence, he de-risks the path for transformative biopharmaceutical innovations.

Creating a world-class cGMP-compliant ecosystem in the Mumbai Biocluster to accelerate the trajectory of global drug development.

With over two decades of expertise in protein analytics and upstream processing, he advises global stakeholders on designing and scaling innovations from India to the world stage.

Dr. Jain's vision is to create a sustainable and scalable ecosystem for biopharmaceutical innovation.

Mentorship & Academic Leadership

Empowering the next generation of Biopharma Pioneers.

For over two decades, Dr. Ratnesh Jain has mentored M.Tech and PhD scholars who now lead R&D, manufacturing, regulatory and strategy roles across Indian and global biopharma. His laboratory serves as an incubator for rigorous scientific inquiry and practical application.

Primary Areas of Research

Bioprocess Technology

Optimization of upstream and downstream processes for biologics manufacturing.

New Approach Methodologies (NAMs)

Organ-on-chip platforms for preclinical testing and safety assessment.

Monoclonal Antibodies (mAbs)

Development and optimization of therapeutic antibodies and biosimilars.

Cell & Gene Therapy (CGT)

Advancing the manufacturing and delivery of regenerative medicinal products.

Select Alumni Trajectories

"I don't just teach; I build the leadership bench for the next decade of biopharma."
Venture Incubation

Translating Laboratory Breakthroughs to Global Markets.

Many of Dr. Jain's students and collaborators have gone on to build ventures in biologics, devices, NAMs and digital health. He supports them in shaping technology, business models and regulatory strategy.

"I am a source of quality deal flow and a credible scientific co-pilot for founders building in the life sciences."
Strategic Advisory

Architecting the Future of Biotech.

Dr. Jain serves as a strategic bridge for deep-tech startups, providing the technical validation and operational guidance required to scale complex biological ventures.

Due Diligence

Helping Venture Capital firms evaluate the scientific viability and scalability of biopharma candidates through comprehensive technical assessments.

Operational Roadmap

Setting up scalable GLP labs and bioprocessing units that meet international regulatory standards for seamless technology transfer.

Regulatory Strategy

Developing comprehensive regulatory pathways for novel biologics and complex generics to accelerate market approval.

Tech Transfer

Facilitating seamless technology transfer from lab to commercial manufacturing with minimal loss of yield or quality.

Fundraising Support

Preparing investor decks and scientific narratives that effectively communicate the value proposition of biotech ventures.

Manufacturing Scale-up

Guiding process optimization for commercial-scale production while maintaining product quality and regulatory compliance.

Notable Venture Engagements

"Every startup I support must be able to defend its science in the boardroom and at the regulator's table."
Industrial Consulting

Global Collaboration & Technical Support.

Dr. Jain provides strategic consulting to biopharma companies, helping them navigate complex regulatory landscapes, optimize manufacturing processes, and accelerate product development. His expertise spans from early-stage research to commercial-scale production.

Strategic Consulting Focus

01

Bioprocess Development

Optimization of mAbs, vaccines, and peptide manufacturing processes for efficiency and regulatory compliance.

02

Tech Transfer & Scale-Up

Enabling seamless technology transfer and manufacturing scale-up for India and regulated global markets.

03

Regulatory & Scientific Support

Scientific support for regulatory filings, agency interactions, and CMC strategy for FDA/EMA-ready programs.

04

Due Diligence & Review

Technical due diligence and investment review for biopharmaceutical assets and licensing opportunities.

Outcomes & Impact
  • Supported FDA/EMA-ready development for selected biologic programs
  • Helped companies de-risk CMC strategies and accelerate timelines
  • Enabled cost-effective, globally competitive manufacturing from India
  • Guided regulatory interactions for complex biologic and peptide filings
  • Developed regulatory strategies for complex generics and biosimilars
  • Conducted technical due diligence assessments for biopharma investments
  • Implemented quality by design principles across manufacturing facilities
  • Trained professionals in advanced bioprocess technologies
"I architect biopharma ecosystems that translate complex science into scalable, globally competitive therapeutics."
Regional Hub Development

The Mumbai Biocluster.

Mumbai Biocluster is a hub-and-spoke platform that we are building to accelerate regulatory approval and commercialization of next-generation therapies from India – spanning biologics, NAMs, rare diseases and cell and gene therapies.

Visit Mumbai Biocluster Website →

Our Mission

Capacity building and training

For next-generation biopharma talent

Shared translational R&D infrastructure

And bioprocess platforms

Regulatory readiness programs

For biologics, NAMs and advanced therapies

Investor-connect and industry–academia interfaces

To accelerate commercialization

Our Vision

"To become a thriving hub that fosters cutting-edge research, nurtures innovation and creates a platform that would translate early-stage start-up and academic innovations into clinical stage biotechnology companies."

Mumbai Biocluster Facility

What the Biocluster Offers

01

Training & Skilling

Hands-on programs for bioprocess engineers, regulatory scientists, and translational researchers.

02

Translational R&D

Bioprocess platforms for mAbs, vaccines, peptides, and cell/gene therapy enabling research.

03

NAMs & Organoid Capabilities

Organ-on-chip, organoid models, and new approach methodologies for preclinical innovation.

04

Industry-Academia-Investor Interfaces

Structured interactions connecting research labs, companies, and capital for translational outcomes.

Partner with Us

Explore co-investment, strategic partnerships, and program-based collaborations with Mumbai Biocluster.

Get in Touch

ICT Mumbai Research Foundation, India

Single-use cGMP Facility

State-of-the-art facility for bioprocess development and pilot manufacturing with:

  • Modular cleanroom suites
  • Single-use bioreactor systems
  • Downstream processing capabilities
  • Analytical development labs
Networking Platforms

Curated Collaboration Hubs.

Dr. Jain curates platforms where regulators, industry leaders, and scientists converge to unlock collaborations, deals and policy direction. These initiatives have facilitated over 120 partnerships and $45M in funding connections.

CITATION

Dr Vikram Sarabhai

SARABHAI AROGYA DRISHTI GAURAV

Promoting Scientific Ecosystems in India

Dr Ratnesh Jain

In recognition of distinguished leadership in building a collaborative biopharma ecosystem that brings together translational research, scientific talent, shared platforms and strategic partnerships.

As Founder and Director of Mumbai Biocluster, Dr Ratnesh Jain has advanced an integrated model connecting research, people and platforms, while supporting training, entrepreneurship, infrastructure and industry engagement.

Inspired by Dr Vikram Sarabhai’s visionary legacy, his work exemplifies the power of institution-building and collaboration in advancing India’s scientific capabilities.

The Bharat Life Sciences Award confers the Sarabhai Arogya Drishti Gaurav (Promoting Scientific Ecosystems in India) upon Dr Ratnesh Jain, Institute of Chemical Technology, Mumbai, and Mumbai Biocluster.

Recognition • 2026

Bharat Life Sciences Award 2026

Recognising Dr. Ratnesh Jain for his contribution to the development of India’s life sciences ecosystem.

Dr. Ratnesh Jain receiving the Sarabhai Arogya Drishti Gaurav award
Sarabhai Arogya Drishti Gaurav

Promoting Scientific Ecosystem in India

Dr. Ratnesh Jain has been honoured with the Bharat Life Sciences Award 2026 for his contribution to life sciences ecosystem development and ecosystem building in India.

The Bharat Life Sciences Award is a first-of-its-kind national platform organised by the Federation of Indian Chambers of Commerce & Industry (FICCI) in partnership with Eli Lilly and Company (India). The inaugural edition recognises contributions spanning scientific excellence, innovation, public health and the wider life sciences ecosystem.

The recognition was announced directly at the award ceremony, making the moment a significant milestone in Dr. Jain’s journey of building platforms, collaborations and capabilities that connect academia, industry, innovation and entrepreneurship.

First instituted in 2026, the Bharat Life Sciences Award marks a new national platform for recognising people and institutions contributing to the growth and development of India’s life sciences ecosystem.
FICCIEli Lilly and Company (India)Bharat Life Sciences Award 2026

Connect with Dr. Ratnesh Jain

My work sits at the intersection of science, regulation and capital – to help India become a global leader in advanced biopharmaceuticals.

For strategic consulting, ecosystem partnerships or speaking engagements:

Email LinkedIn